Canadian SMA Families Waiting for Spinraza Approval
This video from CTV News features the Bartlett family from Ontario, Canada. Sarah and Myles Bartlett are understandably excited about Spinraza and the potential the new drug has to treat their daughter Stella, who was born with spinal muscular atrophy (SMA). However, they’re still waiting for the drug to approved by the Canadian government.
As well as waiting for approval, the SMA community in Canada is concerned about the high price tag attached to the drug. Currently, the price of the first injection is US$750,000, with annual injections for the rest of their children’s lives costing US$375,000 each year.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.